Biochemical and Biophysical Research Communications, Vol.506, No.1, 81-86, 2018
A valine-to-lysine substitution at position 210 induces structural conversion of prion protein into a beta-sheet rich oligomer
Prion diseases are fatal neurodegenerative diseases associated with structural conversion of alpha-helical prion protein (PrP) into its beta-sheet rich isoform (PrPSc). Previous genetic analyses have indicated that several amino acid residues involved in the hydrophobic core of PrP (such as V180, F198, and V210) play a critical role in the development of prion diseases. To understand how these hydrophobic residues would contribute to the alpha-to-beta conversion process of PrP, we substituted the V210 residue with bulkier (V210F, V210I, and V210L), smaller (V210A), and charged amino acids (V210K) and characterized its effects. Interestingly, although most of the mutations had little or no effect on the biochemical properties of PrP, the V210K mutation induced structural conversion of PrP into a beta-structure. The beta-inducing effect was prominent and observed even under a physiological condition (i.e., in the absence of denaturant, acidic pH, reducing agent, and high temperature) in contrast to the disease-associated mutations in the PrP gene. We also examined structural features of V210K PrP using guanidine-hydrochloride unfolding, dynamic light scattering, 8-anilino-1-naphthalene sulfonate fluorescence, and electron microscopy, and revealed that V210K PrP assembles into a non-fibrillar beta-rich oligomer. Thus, the alpha-to-beta conversion can be induced by introduction of a charged residue into the hydrophobic core, which provide novel insight into the structural dynamics of PrP. (C) 2018 Elsevier Inc. All rights reserved.